Intra-uterine insemination for unexplained subfertility

被引:27
|
作者
Veltman-Verhulst, Susanne M. [1 ]
Hughes, Edward [2 ]
Ayeleke, Reuben Olugbenga [3 ]
Cohlen, Ben J. [4 ]
机构
[1] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Room F5-126,POB 85500, NL-3508 GA Utrecht, Netherlands
[2] McMaster Univ, Dept Obstet & Gynaecol, ONE Fertil, Hamilton, ON, Canada
[3] Univ Auckland, Dept Obstet & Gynaecol, Auckland, New Zealand
[4] Isala Clin, Dept Obstet & Gynaecol, Zwolle, Netherlands
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2016年 / 02期
关键词
Pregnancy Rate; Coitus; Fertile Period [physiology; Infertility [therapy; Insemination; Artificial [adverse effects; methods; Live Birth [epidemiology; Ovulation Induction [adverse effects; Pregnancy; Multiple; Randomized Controlled Trials as Topic; Time Factors; Female; Humans; Male; CONTROLLED OVARIAN HYPERSTIMULATION; HUMAN MENOPAUSAL GONADOTROPIN; ORDER MULTIPLE PREGNANCY; OVULATION INDUCTION; CLOMIPHENE CITRATE; TIMED INTERCOURSE; INTERMEDIATE PROGNOSIS; EXPECTANT MANAGEMENT; SUPEROVULATED CYCLES; NATURAL INTERCOURSE;
D O I
10.1002/14651858.CD001838.pub5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Intra-uterine insemination (IUI) is a widely used fertility treatment for couples with unexplained subfertility. Although IUI is less invasive and less expensive thAppendixan in vitro fertilisation (IVF), the safety of IUI in combination with ovarian hyperstimulation (OH) is debated. The main concern about IUI treatment with OH is the increase in multiple pregnancy rate. This is an update of a Cochrane review (Veltman-Verhulst 2012) originally published in 2006 and updated in 2012. Objectives To determine whether, for couples with unexplained subfertility, IUI improves the live birth rate compared with timed intercourse (TI), or expectant management, both with and without ovarian hyperstimulation (OH). Search methods We searched the Cochrane Gynaecology and Fertility (formerly Cochrane Menstrual Disorders and Subfertility Group) Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, inception to Issue 11, 2015), Ovid MEDLINE, Ovid EMBASE, PsycINFO and trial registers, all from inception to December 2015 and reference lists of articles. Authors of identified studies were contacted for missing or unpublished data. The evidence is current to December 2015. Selection criteria Truly randomised controlled trial (RCT) comparisons of IUI versus TI, in natural or stimulated cycles. Only couples with unexplained subfertility were included. Data collection and analysis Two review authors independently performed study selection, quality assessment and data extraction. We extracted outcomes, and pooled data and, where possible, we carried out subgroup and sensitivity analyses. Main results We included 14 trials including 1867 women. IUI versus TI or expectant management both in natural cycle Live birth rate (all cycles) There was no evidence of a difference in cumulative live births between the two groups (Odds Ratio (OR) 1.60, 95% confidence interval (CI) 0.92 to 2.78; 1 RCT; n = 334; moderate quality evidence). The evidence suggested that if the chance of a live birth in TI was assumed to be 16%, that of IUI would be between 15% and 34%. Multiple pregnancy rate There was no evidence of a difference in multiple pregnancy rate between the two treatment groups (OR 0.50, 95% CI 0.04 to 5.53; 1 RCT; n = 334; moderate quality evidence). IUI versus TI or expectant management both in stimulated cycle Live birth rate (all cycles) There was no evidence of a difference between the two treatment groups (OR 1.59, 95% CI 0.88 to 2.88; 2 RCTs; n = 208; I-2 = 72%; moderate quality evidence). The evidence suggested that if the chance of achieving a live birth in TI was assumed to be 26%, the chance of a live birth with IUI would be between 23% and 50%. Multiple pregnancy rate There was no evidence of a difference in multiple pregnancy rates between the two treatment groups (OR 1.46, 95% CI 0.55 to 3.87; 4 RCTs, n = 316; I-2 = 0%; low quality evidence). IUI in a natural cycle versus IUI in a stimulated cycle Live birth rate (all cycles) An increase in live birth rate was found for women who were treated with IUI in a stimulated cycle compared with those who underwent IUI in natural cycle (OR 0.48, 95% CI 0.29 to 0.82; 4 RCTs, n = 396; I-2 = 0%; moderate quality evidence). The evidence suggested that if the chance of a live birth in IUI in a stimulated cycle was assumed to be 25%, the chance of a live birth in IUI in a natural cycle would be between 9% and 21%. Multiple pregnancy rate There was no evidence of a difference in multiple pregnancy rate between the two treatment groups (OR 0.33, 95% CI 0.01 to 8.70; 2 RCTs; n = 65; low quality evidence). IUI in a stimulated cycle versus TI or expectant management in a natural cycle Live birth rate (all cycles) There was no evidence of a difference in live birth rate between the two treatment groups (OR 0.82, 95% CI 0.45 to 1.49; 1 RCT; n = 253; moderate quality evidence). The evidence suggested that if the chance of a live birth in TI or expectant management in a natural cycle was assumed to be 24%, the chance of a live birth in IUI in a stimulated cycle would be between 12% and 32%. Multiple pregnancy rate There was no evidence of a difference in multiple pregnancy rate between the two treatment groups (OR 2.00, 95% CI 0.18 to 22.34; 2 RCTs; n = 304; moderate quality evidence). IUI in natural cycle versus TI or expectant management in stimulated cycle Live birth rate (all cycles) There was evidence of an increase in live births for IUI (OR 1.95, 95% CI 1.10 to 3.44; 1 RCT, n = 342; moderate quality evidence). The evidence suggested that if the chance of a live birth in TI in a stimulated cycle was assumed to be 13%, the chance of a live birth in IUI in a natural cycle would be between 14% and 34%. Multiple pregnancy rate There was no evidence of a difference in multiple pregnancy rate between the groups (OR 1.05, 95% CI 0.07 to 16.90; 1 RCT; n = 342; moderate quality evidence). The quality of the evidence was assessed using GRADE methods. Quality ranged from low to moderate, the main limitation being imprecision in the findings for both live birth and multiple pregnancy.
引用
收藏
页数:90
相关论文
共 50 条
  • [41] Timed intercourse in association with controlled ovarian hyperstimulation as the first-line treatment of couples with unexplained subfertility
    Martins Radaelli, Moacir Rafael
    Mingetti-Camara, Vania Cibelle
    Nakano, Raul
    Ceschin, Nathan Ichikawa
    Almodin Cerialle, Paula Motta
    Almodin, Carlos Gilberto
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2022, 26 (04): : 612 - 619
  • [42] Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial
    Berker, Bulent
    Kahraman, Korhan
    Taskin, Salih
    Sukur, Yavuz Emre
    Sonmezer, Murat
    Atabekoglu, Cem Somer
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 284 (06) : 1561 - 1566
  • [43] Study of Endometrial and Uterine Doppler Markers when Using Letrozole and Clomiphene Citrate in Subfertile Patients with PCOS or Unexplained Subfertility
    Almamou, Median Atia Alkhalaf
    Kurjak, Asim
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2020, 8 (07): : 24 - 31
  • [44] An online survey of specialists' opinion on first line management options for unexplained subfertility
    Nandi, Anupa
    Gudi, Anil
    Shah, Amit
    Homburg, Roy
    HUMAN FERTILITY, 2015, 18 (01) : 48 - 53
  • [45] IVF for unexplained subfertility; whom should we treat?
    van Eekelen, R.
    van Geloven, N.
    van Wely, M.
    Bhattacharya, S.
    van der Veen, F.
    Eijkemans, M. J.
    McLernon, D. J.
    HUMAN REPRODUCTION, 2019, 34 (07) : 1249 - 1259
  • [46] MicroRNA regulation of Transthyretin in trophoblast differentiation and Intra-Uterine Growth Restriction
    Saha, Sarbani
    Chakraborty, Shreeta
    Bhattacharya, Agnihotri
    Biswas, Arati
    Ain, Rupasri
    SCIENTIFIC REPORTS, 2017, 7
  • [47] A COMPARATIVE EVALUATION OF THE MULTILOAD 250 AND MULTILOAD 375 INTRA-UTERINE DEVICES
    Lovset, Tor
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1990, 69 (06) : 521 - 526
  • [48] IMPORTANCE OF PERIFOLLICULAR VASCULARITY IN PREDICTING OUTCOME IN INTRA UTERINE INSEMINATION CYCLES
    Ray, Rajat Kumar
    Samal, Sunita
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2019, 8 (09): : 586 - 589
  • [49] Who is preferred to-Do Intra Uterine Insemination? Physician or Midwife
    Farimani, M.
    Amiri, A.
    Yavangi, M.
    Rabiee, S.
    Zamani, M.
    JOURNAL OF RESEARCH IN HEALTH SCIENCES, 2006, 6 (01) : 32 - 34
  • [50] Intra-uterine growth retardation after prenatal administration of Ginkgo biloba to rats
    Pinto, Rafael M.
    Fernandes, Eduardo S.
    Reis, Joao E. P.
    Peters, Vera M.
    Guerra, Martha de O.
    REPRODUCTIVE TOXICOLOGY, 2007, 23 (04) : 480 - 485